secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2025-07-28T23:59:59+00:00
Accession:  0001156039-25-000118
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health elects Steven H. Collis to board, effective Aug 1, 2025
-----------------------------------------------------------------------

- Steven H. Collis, Executive Chairman of Cencora, elected as independent director effective Aug 1, 2025.
- Collis appointed to Audit and Finance Committees; qualifies as audit committee financial expert.
- Collis served as Cencora (formerly AmerisourceBergen) CEO from 2011 to 2024, leading strategic transformation.
- Board Chair Ramey Peru cites Collis's leadership and operational expertise to support Elevance's strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000118/0001156039-25-000118-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603925000118/elv-20250728.htm
  HTML page:      https://secwatch.observer/filing/0001156039-25-000118

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer